Evaluating everolimus for the treatment of breast cancer-Reference-Cited by-同舟云学术

Evaluating everolimus for the treatment of breast cancer

Published:2023-05-18 Issue:10 Volume:24 Page:1105-1111
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Moreau-Bachelard Camille¹^ORCID,Robert Marie¹,Gourmelon Carole¹,Bourbouloux Emmanuelle¹,Patsouris Anne²,Frenel Jean-Sébastien¹,Campone Mario¹

Affiliation:

1. Medical Oncology, ICO Centre René Gauducheau, Oncology, Nantes, France

2. Medical Oncology, ICO Centre Paul Papin, Oncology, Angers, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2214677

Reference52 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer

3. Targeting the PI3K/AKT/mTOR pathway in hormone-positive breast cancer | SpringerLink [Internet]. [cited 2021 Oct 29];Availablefrom: https://link.springer.com/article/10.1007%2Fs40265-020-01394-w

4. SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted treatments for vascular malformations: current state of the art;Journal of Thrombosis and Haemostasis;2024-08

2. Newer combination treatments for breast cancer coexisting with acute myeloid leukemia in the novel regimens era: A case report and literature review;Oncology Letters;2024-07-23

3. Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies;Cancers;2024-07-07

4. A review of endocrine therapy for hormone-dependent breast cancer;Siberian journal of oncology;2024-07-07

5. Le neoplasie neuroendocrine della mammella: inquadramento diagnostico e gestione clinica;L'Endocrinologo;2024-06